This Article Full Text Full Text (PDF) All Versions of this Article: 0008-5472.CAN-09-0415v1 69/15/6158    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Google Scholar Articles by Welsh, M. M. Articles by Nelson, H. H. PubMed PubMed Citation Articles by Welsh, M. M. Articles by Nelson, H. H.

CTLA4 Variants, UV-Induced Tolerance, and Risk of Non-Melanoma Skin Cancer

¹ Department of Environmental Health, Harvard School of Public Health; ² Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts; ³ Section of Dermatology, Department of Medicine and ⁴ Department of Pathology, Dartmouth Hitchcock Medical Center; ⁵ Section of Biostatistics and Epidemiology, Department of Community and Family Medicine, and the Norris Cotton Cancer Center, Dartmouth Medical School, Lebanon, New Hampshire; and ⁶ Division of Epidemiology and Community Health and ⁷ Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota

Requests for reprints: Heather H. Nelson, University of Minnesota Cancer Center, 554A Cancer Center Research Building, 420 Delaware Street Southeast, MMC 806, Minneapolis, MN 55455. Phone: 612-626-9887; Fax: 612-626-4842; E-mail: hhnelson{at}umn.edu.

Key Words: CTLA4 • haplotypes • cancer immunity • skin cancer

Although skin tumors are highly immunogenic, exposure to UV radiation is known to suppress immune responses via regulatory T cells. Specifically, the activity of cytotoxic lymphocyte-associated antigen-4 (CTLA-4) is integral in regulating the development of UV-induced tolerance and, concomitantly, skin cancers. Due to the inverse relationship between tumor surveillance and autoimmunity, we hypothesize that the same genetic variant in the CTLA4 locus that increases risk for autoimmune diseases is associated with decreased risk of non-melanoma skin cancer (NMSC). We analyzed whether the polymorphism CT60 or haplotypes of CTLA4 influence odds of developing the major types of NMSC, basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), in a population-based case-control study of Caucasians in New Hampshire (849 controls, 930 BCC, and 713 SCC). The CTLA4 CT60 GG genotype was associated with decreased odds for BCC and SCC, controlling for age, sex, lifetime number of severe sunburns, and skin type [BCC: odds ratio (OR), 0.7; 95% confidence interval (95% CI), 0.5-0.9; SCC: OR, 0.7; 95% CI, 0.5-1.0]. For BCC, this decrease was apparent largely among those with a higher lifetime number of severe sunburns (P_interaction = 0.0074). There were significantly decreased odds of disease associated with two haplotypes, which possess the CT60 G allele. Additionally, lifetime number of severe sunburns modestly altered the effects of the CTLA4 haplotypes in BCC, and the association seemed driven by the CT60 single nucleotide polymorphism. In conclusion, genetic variation at the CTLA4 locus may be etiologically important in NMSC, the most prevalent malignancy in the United States. [Cancer Res 2009;69(15):6158–63]

This article has been cited by other articles:

				Polymorphisms in CTLA4 Confer Susceptibility to Nonmelanoma Skin Cancers Journal Watch Dermatology, September 25, 2009; 2009(925): 1 - 1. [Full Text]